| Project/Area Number |
23659543
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Dermatology
|
|---|
| Research Institution | Chiba University |
|---|
Principal Investigator |
HIROYUKI Matsue 千葉大学, 医学(系)研究科(研究院), 教授 (10250424)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
KAMATA Noriaki 千葉大学, 医学部附属病院, 講師 (00334186)
TOGAWA Yaei 千葉大学, 大学院医学研究院, 助教 (90361427)
OHARA Osamu (財)かずさDNA 研究所, ヒトゲノム研究部, 部長 (20370926)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Keywords | がん / 悪性黒色腫 / がん幹細胞 |
|---|
| Research Abstract |
Cancer is not a group composed of tumor cells derived from a single malignant cell, but a group of the cells possessing accumulated genetic diversities derived from a cancer stem cell. To eradicate cancer, all malignant cells forming cancer must become therapeutic targets. The purpose of this proposed pilot feasibility study was ultimately to establish a reliable method to analyze genetic diversities of malignant melanoma using next-generation sequencing. The first step was to evaluate individual differences and reproducibility of the method from the results of skin-derived cells.
|
